Lecithin: cholesterol acyltransferase activity in children and young adults. 1989

T Rönnemaa, and J Viikari, and J Marniemi
Rehabilitation Research Centre of the Social Insurance Institution, Turku, Finland.

The association between serum lecithin: cholesterol acyltransferase (LCAT) activity and demographic and environmental factors, and the correlation of LCAT activity with serum lipids and lipoproteins were studied in a representative series of 1071 9-24-year-old subjects from East and West Finland. LCAT activity was determined by a method involving the use of exogenous substrate. Males had higher LCAT activity than females and subjects from East Finland had significantly higher activity than those from West Finland. LCAT activity tended to be lowest shortly after puberty. Women using oral contraceptives had significantly lower LCAT activity than women not using them. Serum LCAT activity was not associated with body mass index, physical activity index or smoking. Serum LCAT activity correlated positively with most serum lipid and lipoprotein variables. The highest correlation coefficients were found between LCAT activity and total cholesterol. LCAT activity correlated positively with the change in serum total cholesterol which had occurred during the preceding 3 and 6 years in men. Our results suggest that sex hormonal factors are associated with serum LCAT activity. The results are also in accordance with the idea that activity of LCAT increases in response to enhanced demands for cholesterol esterification in plasma.

UI MeSH Term Description Entries
D007862 Phosphatidylcholine-Sterol O-Acyltransferase An enzyme secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma. Lecithin Cholesterol Acyltransferase,Cholesterol Ester Lysolecithin Acyltransferase,Lecithin Acyltransferase,Phosophatidylcholine-Sterol Acyltransferase,Acyltransferase, Lecithin,Acyltransferase, Lecithin Cholesterol,Acyltransferase, Phosophatidylcholine-Sterol,Cholesterol Acyltransferase, Lecithin,O-Acyltransferase, Phosphatidylcholine-Sterol,Phosophatidylcholine Sterol Acyltransferase,Phosphatidylcholine Sterol O Acyltransferase
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands

Related Publications

T Rönnemaa, and J Viikari, and J Marniemi
July 1977, Clinica chimica acta; international journal of clinical chemistry,
T Rönnemaa, and J Viikari, and J Marniemi
September 1998, Progress in lipid research,
T Rönnemaa, and J Viikari, and J Marniemi
January 1991, Methods in enzymology,
T Rönnemaa, and J Viikari, and J Marniemi
September 1972, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
T Rönnemaa, and J Viikari, and J Marniemi
January 1984, Physiologia Bohemoslovaca,
T Rönnemaa, and J Viikari, and J Marniemi
October 1987, Casopis lekaru ceskych,
T Rönnemaa, and J Viikari, and J Marniemi
January 1984, Biology of the neonate,
T Rönnemaa, and J Viikari, and J Marniemi
December 1994, Nihon rinsho. Japanese journal of clinical medicine,
T Rönnemaa, and J Viikari, and J Marniemi
February 1978, Das Medizinische Laboratorium,
T Rönnemaa, and J Viikari, and J Marniemi
December 2000, Biochimica et biophysica acta,
Copied contents to your clipboard!